Precision medicine allows for prediction of drug response and tailoring drug therapy based on genetic variability. This talk will provide examples of precision medicine initiatives at the University of Florida Health. Outcomes specific to CYP2C19 genotype-guided antiplatelet therapy will be described as will other efforts to examine outcomes with pharmacogenomic implementations.